CALIFORNIA BANCORP ANNOUNCES RETIREMENT OF CEO STEVEN SHELTON AND APPOINTMENT OF DAVID RAINER AS CEO GlobeNewswire January 07, 2026 San Diego, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — California BanCorp (the “Company”) (Nasdaq: BCAL), the holding company for California Bank of Commerce, N.A. (the “Bank”), announces that Steven Shelton has retired from the position of […]

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 GlobeNewswire January 07, 2026 MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday,

Freshworks Appoints Kady Srinivasan as Chief Marketing Officer Former Dropbox and Klaviyo executive brings proven track record of driving transformational marketing and revenue growth at high-growth SaaS companies GlobeNewswire January 07, 2026 SAN MATEO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Freshworks (NASDAQ: FRSH), today announced Kady Srinivasan has joined as its Chief Marketing Officer,

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan

Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the

Egle Therapeutics Appoints John Celebi as Chief Executive Officer GlobeNewswire January 07, 2026 PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune diseases and cancer, today announced the appointment of John Celebi,

(NYSE:EBS), GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent's session may be accessed

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 GlobeNewswire January 07, 2026 GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare

Singapore, SG, Jan. 07, 2026 (GLOBE NEWSWIRE) — Indocia today announced that its VIP Whitelisting Round for the $INDO token presale is now live, with limited seats remaining ahead of the upcoming public presale. The VIP round is designed to offer early participation to a select group of contributors before broader market access is opened.

Wellington, New Zealand, Jan. 07, 2026 (GLOBE NEWSWIRE) — Pokiemachines, a new site about pokie machines, announced the results of a comprehensive behavioral study examining how players interact with slot machines in demo mode. The research analyzed over 120,000 demo sessions across desktop and mobile devices, revealing consistent patterns in player engagement, feature preferences, and